Edap Tms SANASDAQ:EDAP
- LAST PRICE2.3600
- TODAY'S CHANGE (%)-0.1100 (-4.4534%)
- Bid / Lots2.3500/ 20
- Ask / Lots2.3700/ 2
- Open / Previous Close2.5200 / 2.4700
- Day Range
- 52 Week Range
- Volume66,807
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EDAP |
|---|---|---|
| 09:32 ET | 300 | 2.52 |
| 09:35 ET | 10009 | 2.525 |
| 09:37 ET | 10000 | 2.4575 |
| 09:39 ET | 20315 | 2.45 |
| 09:50 ET | 15500 | 2.45 |
| 10:11 ET | 300 | 2.43 |
| 10:15 ET | 518 | 2.41 |
| 10:26 ET | 700 | 2.43 |
| 10:33 ET | 200 | 2.41 |
| 10:42 ET | 200 | 2.42 |
| 11:05 ET | 2000 | 2.4 |
| 11:12 ET | 900 | 2.3964 |
| 11:32 ET | 1995 | 2.38 |
| 11:34 ET | 2240 | 2.37 |
| 11:45 ET | 100 | 2.375 |
| 11:48 ET | 100 | 2.39 |
| 11:54 ET | 658 | 2.36 |
Nov 22, 2024
Nov 19, 2024
Nov 7, 2024
*DJ EDAP TMS 3Q Rev $14.4M >EDAP, from 7:05AM ET on Thursday Nov 07, 2024 by Dow Jones
7:05AM ET on Thursday Nov 07, 2024 by Dow JonesEDAP Reports Third Quarter 2024 Financial Results, from 7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
7:00AM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 6, 2024
EDAP to Participate in the 2024 Jefferies London Healthcare Conference, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Edap Tms SA | 91.6M | -3.8x | --- |
Owlet Inc | 70.6M | -2.8x | --- |
Neuronetics Inc | 26.9M | -0.8x | --- |
NantHealth Inc | 54.9K | 0.0x | --- |
908 Devices Inc. | 89.1M | -1.5x | --- |
Brainsway Ltd | 184.6M | -19.4x | --- |
Company Information
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Contact Information
- Headquarters
- Parc Activite La Poudrette LamartineVAULX-EN-VELIN, France 69120
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Marc Oczachowski
- Chief Executive Officer, Director
- Ryan Rhodes
- Global Chief Financial Officer
- Ken Mobeck
- Global Chief Accounting Officer
- Francois Dietsch
- Independent Director
- Pierre Beysson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $91.6M |
|---|---|
Revenue (TTM) | $66.5M |
Shares Outstanding | 37.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.35 |
EPS | $-0.63 |
Book Value | $1.61 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -31.98% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
